24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

All regions

Cancer Industry, October 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, drug, more »


 
1-20 of about 141 000 reports for Cancer

Malignant Melanoma: KOL Insight

Malignant Melanoma: KOL Insight

  • $ 6 495
  • Industry report
  • October 2014
  • by Firstword Pharma

... And the jonsson comprehensive cancer center, californiadr. Kim margolin, clinical and research director of melanoma and renal cancer clinical trials group, university ...

AB Science (Symbol:AB) SWOT Analysis, Strategy, Revenues and Profits

AB Science (Symbol:AB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... To meet various medical needs. It concentrates on therapies for the treatment of cancer, chronic inflammatory diseases and central nervous system disorders. The company's pipeline includes both human ...

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Of parkinson's disease. The company's att-11t is a therapeutic compound used in the treatment of metastatic solid tumors such as colorectal cancer, lung cancer and ovarian cancer. It markets products through ...

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Development and manufacturing of vaccines for the treatment of cancer and infectious diseases. The company's pipeline product portfolio includes cancer products such as prostvac, cv-301 colon, cv-301 bladder ...

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Such as bcr-abl with their downstream signaling molecules including, mapk and akt to regulate cancer proliferation and survival. The company's liposomal bcl-2 is a protein, which regulates programmed cell death ...

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And clinical development of pharmaceutical products utilizing its platform technology. The company focuses on developing drugs that are used in the treatment of diseases such as cancer, sexual dysfunction ...

Cancer Research Technology Limited SWOT Analysis, Strategy, Revenues and Profits

Cancer Research Technology Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... About globaldata contact us disclaimer note*: some sections may be missing if data is unavailable for the company list of tables cancer research ...

Cancer Research UK SWOT Analysis, Strategy, Revenues and Profits

Cancer Research UK SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Diagnosis, detection and prognosis; prevention; and treatment. Cruk provides treatment for various types of cancer such as anal cancer, bladder cancer, bowel cancer, cervical cancer, eye cancer, gastric ...

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... And commercializes genomic-based clinical laboratory tests. It develops diagnostic tests such as, colonsentry and sentinelgx. Genenews colonsentry is a blood test for colorectal cancer and sentinelgx is used in whole ...

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Its product also provides molecular profiles for myelodysplastic syndromes (mds), myeloid malignancies, acute myeloid leukemia (aml) in heme, and melanoma for skin cancer. The company is a wholly owned ...

About 15 000 reports for Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Cancer Statistics, 2013
  • January 2013
    20 pages
  • Cancer  

  • United States  

    North America  

View report >

66 Companies for Cancer

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Cepheid

United States

Eli Lilly and Co.

United States

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.